Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuro-Immune Interactions at Barrier Surfaces.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Clinically isolated syndromes.
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
[Neurophysiology in Guillain-Barré syndrome].
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Trimesta (Oral Estriol)
FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
Immunology 2016
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis Patients
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
FOCIS 2013: Improving Human Health Through Immunology
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.

Pages